Eriko Iguchi

578 total citations
28 papers, 337 citations indexed

About

Eriko Iguchi is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Eriko Iguchi has authored 28 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 9 papers in Epidemiology and 9 papers in Cancer Research. Recurrent topics in Eriko Iguchi's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Eriko Iguchi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Eriko Iguchi collaborates with scholars based in Japan, United States and Italy. Eriko Iguchi's co-authors include Haruhiko Takeda, Ryuichi Kita, Tōru Kimura, Hiroki Nishikawa, Yukio Osaki, Sumio Saito, Azusa Sakamoto, Keiichi Hatamaru, Akihiro Nasu and Fumihiro Matsuda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Eriko Iguchi

27 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eriko Iguchi Japan	13	219	162	72	57	54	28	337
Luciana Kikuchi Brazil	13	263 1.2×	240 1.5×	68 0.9×	63 1.1×	66 1.2×	22	417
Xubiao Wei China	12	227 1.0×	107 0.7×	61 0.8×	77 1.4×	68 1.3×	27	407
Philippe Kolly Switzerland	9	189 0.9×	209 1.3×	47 0.7×	34 0.6×	62 1.1×	10	306
Sawako Uchida‐Kobayashi Japan	11	293 1.3×	262 1.6×	69 1.0×	99 1.7×	45 0.8×	59	474
Jinglong Chen China	10	203 0.9×	116 0.7×	51 0.7×	87 1.5×	52 1.0×	19	344
Yuki Tahata Japan	10	244 1.1×	240 1.5×	61 0.8×	85 1.5×	32 0.6×	34	412
Tomoaki Iwata Japan	11	157 0.7×	179 1.1×	113 1.6×	101 1.8×	76 1.4×	36	439
Shuya Matsuda Japan	9	212 1.0×	185 1.1×	53 0.7×	43 0.8×	49 0.9×	18	308
Junichi Toshimori Japan	10	214 1.0×	166 1.0×	117 1.6×	75 1.3×	79 1.5×	16	395
Morven Cunningham United Kingdom	10	222 1.0×	184 1.1×	48 0.7×	74 1.3×	24 0.4×	21	373

Countries citing papers authored by Eriko Iguchi

Since Specialization

Citations

This map shows the geographic impact of Eriko Iguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Iguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Iguchi more than expected).

Fields of papers citing papers by Eriko Iguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Iguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Iguchi. The network helps show where Eriko Iguchi may publish in the future.

Co-authorship network of co-authors of Eriko Iguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Iguchi. A scholar is included among the top collaborators of Eriko Iguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Iguchi. Eriko Iguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ueno, Masayuki, Haruhiko Takeda, Atsushi Takai, et al.. (2025). Acquisition Process and Clinical Relevance of dMMR ‐Associated Mutational Signatures in Hepatocellular Carcinoma. Liver International. 45(7). e70197–e70197.

Iguchi, Eriko, Atsushi Takai, Haruhiko Takeda, et al.. (2025). Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of NFKBIZ mRNA. Proceedings of the National Academy of Sciences. 122(23). e2500820122–e2500820122. 1 indexed citations

Mishima, Masako, Atsushi Takai, Haruhiko Takeda, et al.. (2024). TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential. The Journal of Pathology. 264(3). 318–331. 6 indexed citations

Takeda, Haruhiko, Atsushi Takai, Eriko Iguchi, et al.. (2023). Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology Communications. 7(3). e0047–e0047. 2 indexed citations

Takeda, Haruhiko, Yoshihide Ueda, Atsushi Takai, et al.. (2022). Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing. Scientific Reports. 12(1). 7083–7083. 5 indexed citations

Iguchi, Eriko, Stanislav O. Zakharkin, Christopher J. LaRocca, et al.. (2021). Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion. Molecular Therapy — Oncolytics. 20. 659–668. 10 indexed citations

Eso, Yuji, Shigeharu Nakano, Masako Mishima, et al.. (2021). A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubbles. Quantitative Imaging in Medicine and Surgery. 11(6). 2766–2774. 3 indexed citations

Iguchi, Eriko, Atsushi Takai, Haruhiko Takeda, et al.. (2021). Author Correction: DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis. Scientific Reports. 11(1). 14037–14037. 1 indexed citations

Takeda, Haruhiko, Atsushi Takai, Eriko Iguchi, et al.. (2021). Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus. Carcinogenesis. 42(5). 672–684. 6 indexed citations

10.

Iguchi, Eriko, Atsushi Takai, Haruhiko Takeda, et al.. (2020). DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis. Scientific Reports. 10(1). 21268–21268. 8 indexed citations

11.

Takeda, Haruhiko, Atsushi Takai, Ken Kumagai, et al.. (2020). Multiregional whole‐genome sequencing of hepatocellular carcinoma with nodule‐in‐nodule appearance reveals stepwise cancer evolution. The Journal of Pathology. 252(4). 398–410. 21 indexed citations

12.

Eso, Yuji, Tadayuki Kou, Hiroki Nagai, et al.. (2019). Utility of ultrasound‐guided liver tumor biopsy for next‐generation sequencing‐based clinical sequencing. Hepatology Research. 49(5). 579–589. 5 indexed citations

13.

Comba, Andrea, Luciana L. Almada, Ezequiel J. Tolosa, et al.. (2015). Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic Acid. Journal of Biological Chemistry. 291(4). 1933–1947. 16 indexed citations

14.

Takeda, Haruhiko, Hiroki Nishikawa, Eriko Iguchi, et al.. (2013). Effect of treatment with branched‐chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma. Hepatology Research. 44(3). 302–312. 22 indexed citations

15.

Nishikawa, Hiroki, Eriko Iguchi, Tadashi Inuzuka, et al.. (2012). The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients. BMC Research Notes. 5(1). 135–135. 20 indexed citations

16.

Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). The Effect of Long-term Supplementation With Branched-chain Amino Acid Granules in Patients With Hepatitis C Virus-related Hepatocellular Carcinoma After Radiofrequency Thermal Ablation. Journal of Clinical Gastroenterology. 47(4). 359–366. 35 indexed citations

17.

Takeda, Haruhiko, Hiroki Nishikawa, Eriko Iguchi, et al.. (2012). Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases. Clinical Journal of Gastroenterology. 5(6). 407–412. 16 indexed citations

18.

Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine. 4(3). 381–386. 14 indexed citations

19.

Nishikawa, Hiroki, Eriko Iguchi, Azusa Sakamoto, et al.. (2012). Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib. Molecular and Clinical Oncology. 1(2). 241–248. 19 indexed citations

20.

Nishikawa, Hiroki, Yukio Osaki, Eriko Iguchi, et al.. (2012). Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. Journal of Gastroenterology. 48(8). 951–965. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact